Literature DB >> 29868806

Acute Kidney Injury.

Andrew S Levey1, Matthew T James2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29868806     DOI： 10.7326/L18-0017

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Relationship between early serum sodium and potassium levels and AKI severity and prognosis in oliguric AKI patients.

Authors:  Dao-Nan Chen; Jiang Du; Yun Xie; Ming Li; Rui-Lan Wang; Rui Tian
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

2.  Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) overexpression alleviates endoplasmic reticulum stress after acute kidney injury.

Authors:  Hao Pan; Zhizhi Hu; Zhongwen Shao; Yong Ning
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

3.  Expression changes of autophagy-related proteins in AKI patients treated with CRRT and their effects on prognosis of adult and elderly patients.

Authors:  Yang Zhang; Ling Wang; Lei Meng; Guang-Ke Cao; Yu-Liang Zhao; Yu Wu
Journal:  Immun Ageing       Date:  2018-10-03       Impact factor: 6.400

4.  Activation of aryl hydrocarbon receptor by 6-formylindolo[3,2-b]carbazole alleviated acute kidney injury by repressing inflammation and apoptosis.

Authors:  Sibei Tao; Fan Guo; Qian Ren; Jing Liu; Tiantian Wei; Lingzhi Li; Liang Ma; Ping Fu
Journal:  J Cell Mol Med       Date:  2020-12-06       Impact factor: 5.295

Review 5.  A Comprehensive Review of Receptor-Type Tyrosine-Protein Phosphatase Gamma (PTPRG) Role in Health and Non-Neoplastic Disease.

Authors:  Christian Boni; Carlo Laudanna; Claudio Sorio
Journal:  Biomolecules       Date:  2022-01-06

6.  Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort study.

Authors:  Takeshi Horii; Yoichi Oikawa; Narumi Kunisada; Akira Shimada; Koichiro Atsuda
Journal:  J Diabetes Investig       Date:  2021-08-02       Impact factor: 4.232
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.